HIV Preexposure Prophylaxis (PrEP) with oral antiretroviral drug has been proven to be very effective in preventing HIV exposure. Huang et al. (2018) reported that the CDC analyzed 2014–2016 data from the IQVIA Real World Data — Longitudinal Prescriptions (IQVIA database) and estimated that in 2016, among those older that 16 yrs, 68.7% of PrEP users were white, 11.2% black, 13.1% Hispanic and 4.5% Asian (N=32,853). Over the years, HIV PrEP has been mostly prescribed to male (91.8% in 2014, 94.8% in 2015 and 95.3% in 2016) and paid by commercial health insurance.
In 2010, UNSMH’s soldiers from Nepal brought cholera to Haiti. Medical journals and other scientific sources have reported that despite its poor public health infrastructure and policies, there was no clinical evidence of cholera in Haiti before 2010. On October 21, 2010, the first case of Vibrio cholerae serogroup O1, serotype Ogawa, biotype El Tor was diagnosed in Haiti. On October 27, 2010, the Pan American Health Organization (PAHO) reported a total of 4,722 cholera cases and 303 deaths. By November 14, 2010, MSPP reported a daily average of 688 hospitalizations and 42 deaths; 19 of the deaths came from the Nord Department and 15 from the Artibonite Department.